Dynamic assessment of myelofibrosis progression in myeloproliferative neoplasm mouse model using a minimally invasive evaluation system
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114567 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Xiaohe Gu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Blood Diseases Institute, the Affiliated Hospital of Xuzhou Medical University, 84 West Huaihai Road, Quanshan District, Xuzhou, Jiangsu 221004, Chin…. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Myeloproliferative Disorders. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Myelofibrosis (MF) is the most common complication of myeloproliferative neoplasms (MPNs),which is markedly correlated with a dismal prognosis. Murine model such as the thrombopoietin receptor (MPL)W515L-mutant MPN mouse model functions as a crucial vehicle in disease research, is widely used in basic and applied research on MPNs and MF.However, the lack of methods for dynamic observation of MF progression hinders mechanistic studies and drug development for MF. Here we develop a sensitive, stable and minimally invasive MPN evaluation system to assess the evolution of myelofibrosis in murine model.Key peripheral blood parameters (WBC, RBC, HGB, HCT, PLT, and tumor cell proportion) from MPN mice were analyzed using PCA to reduce dimensionality and generate a comprehensive evaluation score (Y). Based on peripheral blood smear observations and predefined score cut-off values (0.59 and - 0.44), MPN was classified into mild, moderate, and severe stages. Validation conducted across diverse experimental settings yielded outcomes that were in alignment with the pathological grading of myelofibrosis. This system facilitated the dynamic monitoring of MF progression in applied research on pigment epithelium-derived factor treatment for MPN and basic studies on the role of NLRP inflammasomes in the bone marrow microenvironment. We believed that this minimally invasive evaluation system for grading MF severity in MPN mouse model will provide a potential tool for MPN pathogenesis research and targeted therapy development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Blood Diseases Institute, the Affiliated Hospital of Xuzhou Medical University, 84 West Huaihai Road, Quanshan District, Xuzhou, Jiangsu 221004, China; Key Laboratory of Bone Marrow Stem Cell, the Affiliated Hospital of…
Förderung
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Gu, X., Song, X., Yuan, K., Liu, Y., Li, Y., Qiao, J., Ju, W., Yuan, S., Li, Y., Wang, W., & Zeng, L. (2025). Dynamic assessment of myelofibrosis progression in myeloproliferative neoplasm mouse model using a minimally invasive evaluation system. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114567
Vancouver
Gu X, Song X, Yuan K, Liu Y, Li Y, Qiao J, et al. Dynamic assessment of myelofibrosis progression in myeloproliferative neoplasm mouse model using a minimally invasive evaluation system. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114567
BibTeX
@article{Gu2025,
author = {Gu, Xiaohe and Song, Xuguang and Yuan, Ke and Liu, Yahui and Li, Yanjie and Qiao, Jianlin and Ju, Wen and Yuan, Shengnan and Li, Yue and Wang, Weiwei and Zeng, Lingyu},
title = {Dynamic assessment of myelofibrosis progression in myeloproliferative neoplasm mouse model using a minimally invasive evaluation system},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114567}
}
EUVIMED